2025: Cure Parkinson's research highlights from the last year and insights for the year ahead
2024 was another busy year for the research team at Cure Parkinson’s; from the results publication of the phase 2 clinical trial of lixisenatide to the funding of new pre-clinical projects, Cure Parkinson’s has not stopped in its mission to slow, stop or reverse Parkinson’s....
Learn more
Ambroxol: Further validation for potential in Parkinson’s
Small variations in DNA are associated with approximately 1 in 5 of Parkinson’s cases. One of the most common genetic risk factors of developing Parkinson’s occurs in a region of DNA called the GBA gene. This gene provides the code for producing an enzyme – Glucocerebrosidase…
MIRO – A new biomarker for Parkinson’s?
Researchers at Stanford University in the US looking for new biomarkers of Parkinson’s, recently identified a protein called MIRO that in initial data very accurately identifies people with the condition. MIRO is a small protein that attaches to small structures inside our cells called mitochondria….
Tom Isaacs Award winner 2019 – Dr Tilo Kunath
Cure Parkinson’s and Van Andel Research Institute (VAI) have announced Dr. Tilo Kunath as the deserving 2019 winner of the ‘Tom Isaacs Award’. The nominations for the award this year were many and varied but the judges were unanimous in their choice of the winner. …
Phase 2 clinical trial to explore experimental K0706 in early Parkinson’s
Sun Pharma Advanced Research Company (SPARC) is conducting a phase 2 clinical trial to evaluate the safety and effectiveness of its experimental c-Abl inhibitor K0706 in people with early Parkinson’s disease. The trial, which is recruiting approximately 500 participants, will randomly assign participants to receive…
‘Voyager’ recruits patients for phase 2 gene therapy delivery
Voyager Therapeutics recently announced it is recruiting participants for the company’s phase 2 clinical trial testing the safety and effectiveness of the gene therapy VY-AADC02 in people with advanced Parkinson’s disease. Gene therapy is a technique that involves inserting new DNA into a cell using…